SCHEMBL25818442

SCHEMBL25818442

Clc1nc(-c2cccc(-c3ccc4ccc(-c5cccc6ccc7ccccc7c56)cc4c3)c2)nc(-c2ccc3oc4ccccc4c3c2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
PIM1 P11309 1/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
PIM3 Q86V86 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 3/20 0.34
HSD17B10 Q99714 2/20 0.34
MAPT P10636 2/20 0.34
PLA2G10 O15496 1/20 0.34
PLA2G2A P14555 1/20 0.34
PLA2G4A P47712 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25817733 0.93 PLA2G2A (0.39) CASP3SENP7SENP6PIM1CSNK2A2
SCHEMBL26435466 0.91 ALDH1A1 (0.38) CASP3SENP7SENP6KDM4EALDH1A1
SCHEMBL25818443 0.89 AHR (0.38) CASP3SENP7SENP6KDM4EALDH1A1
SCHEMBL25818546 0.89 AHR (0.40) CASP3SENP7SENP6KDM4EALDH1A1
SCHEMBL25818509 0.88 AHR (0.41) CASP3SENP7SENP6KDM4EALDH1A1
SCHEMBL25818478 0.87 PLA2G2A (0.36) CASP3SENP7SENP6PIM1CSNK2A2
SCHEMBL26435469 0.87 ABCG2 (0.40) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL25818465 0.87 ALDH1A1 (0.40) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL25818439 0.87 PLA2G2A (0.42) CASP3SENP7SENP6PIM1CSNK2A2
SCHEMBL25818523 0.86 PLA2G2A (0.40) PIM1CSNK2A2CSNK2BPIM3PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 CASP3 2639/4885SENP7 2200/4885SENP6 1269/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 CASP3 2639/4885SENP7 2200/4885SENP6 1269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.